Brain Metastases in Gynaecologic Cancer: A Retrospective Cohort Study Evaluating Treatment Outcomes, Prognostic Factors, and Overall Survival
Current Oncology · 28.11.2024 · 31 (12) · 7575-7585
DOI: 10.3390/curroncol31120558 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Current Oncology, online erschienen am 28.11.2024. Verfasst von Carly M Cooke und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1N 6N5, Canada. Hauptthemen laut MEDLINE: Brain Neoplasms, Genital Neoplasms, Female. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
(1)
Background
The objectives of this study were to assess survival of patients with a diagnosis of brain metastases secondary to gynaecologic malignancy and the impact of clinicopathological factors on prognosis in this population. (2)
Methods
A retrospective cohort of patients with gynaecologic cancers diagnosed with brain metastases treated with radiation at a tertiary care centre from 1 January 2004 until 30 September 2023 was studied. Kaplan–Meier method and log-rank test were used to evaluate survival, and cox regression was used to identify significant predictive factors of survival. (3)
Results
In total, 103 patients were included in this study. Median age at diagnosis of brain metastases was 59 (range 30–94). Median survival time following diagnosis of brain metastases was 3.6 months (range 0.4–183.8). Survival was significantly longer for patients treated with surgery combined with radiation compared to radiation alone and with stereotactic radiosurgery (SRS) compared to whole brain radiation therapy (WBRT). Cox regression revealed that primary ovarian malignancy, extracranial disease at diagnosis, and ≥3 brain metastases were associated with poorer prognosis, and complete response to prior treatment was associated with more favourable prognosis. (4)
Conclusions
Data from this study will assist in providing evidence-based prognostic information to patients with gynaecologic malignancy diagnosed with brain metastases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
- Division of Radiation Oncology, Department of Radiology, Radiation Oncology and Medical Biophysics, Faculty of Medicine, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
ORCID-Profile: Vimoj J Nair, Rajiv Samant
Zitieren
APA
Cooke, C. M., Babadagli, M. E., Wilson, H., Nair, V. J., Lupe, K., Malone, S., Burgess, L., Faught, W., Samant, R., & Le, T. (2024). Brain Metastases in Gynaecologic Cancer: A Retrospective Cohort Study Evaluating Treatment Outcomes, Prognostic Factors, and Overall Survival. Current Oncology, 31(12), 7575-7585. https://doi.org/10.3390/curroncol31120558
Vancouver
Cooke CM, Babadagli ME, Wilson H, Nair VJ, Lupe K, Malone S, et al. Brain Metastases in Gynaecologic Cancer: A Retrospective Cohort Study Evaluating Treatment Outcomes, Prognostic Factors, and Overall Survival. Current Oncology. 2024;31(12):7575-7585. doi:10.3390/curroncol31120558
BibTeX
@article{Cooke2024,
author = {Cooke, Carly M and Babadagli, M Ege and Wilson, Hillary and Nair, Vimoj J and Lupe, Krystine and Malone, Shawn and Burgess, Laura and Faught, Wylam and Samant, Rajiv and Le, Tien},
title = {Brain Metastases in Gynaecologic Cancer: A Retrospective Cohort Study Evaluating Treatment Outcomes, Prognostic Factors, and Overall Survival},
journal = {Current Oncology},
year = {2024},
volume = {31},
number = {12},
pages = {7575--7585},
doi = {10.3390/curroncol31120558}
}
EUVIMED